Psychometric Properties of the Parent Versions of the Japanese Versions of the Strength and Difficulties Questionnaire: A study on Health Checkups for 5-Year-Old Children in Japan

Introduction In Japan, the effectiveness of health checkups for children aged 5 years has attracted attention as the basis for a support system for early detection and support of children with developmental disabilities. However, these have not yet become statutory health checkups, and their assessment has not been standardized. This study employed the Strength and Difficulties Questionnaire (SDQ) in examining the health of a 5-year-old child. This study aims to demonstrate the scores’ distribution and obtain the standard land and cutoff values of the SDQ. Objectives From 2010 to 2012, children reaching 5 years of age in Kanie-cho, Aichi Prefecture, Japan, underwent a health checkup. Of the 888 children for whom parental consent was obtained, 884 responses without missing values (453 boys: 51.2%, 430 girls: 48.6%) were included in the analysis. Methods SDQ and medical questionnaires for 5-year-old children were sent to the parents with a formal request for approval for the child to participate in the study. Further, the parents were asked to respond to the questionnaire. The Ethics Committee of the Graduate School of Education and Developmental Sciences, Nagoya University approved this study (No.298). Results A confirmatory factor analysis using the maximum likelihood method revealed a factor structure almost identical to that of Goodman (JCPP 1997; 38 581-586). Nonetheless, items 3, 10, 11, 13, 14, and 22 showed high loadings on factors different from those in the original version. Similar to the original version, we set our criteria so that Some and High Needs would be approximately 10% each. Furthermore, we calculated the percentage of children who fell into these categories and found that the scores that fell into the Need category differed from those in the previous study(Table 1). Image: Conclusions Although the five-factor structure of the SDQ was generally accepted, as pointed out in previous studies (Matsuishi et al. Brain Dev 2008;30 410-415 : Iida et al. 2014; 33-41), differences in expression between English and Japanese and cultural differences may have influenced the results. Therefore, it is necessary to be careful in interpreting the results. Additionally, the differences in the Need classification indicated that the difficulty level tends to be slightly lower in the 5-year-old children’s health checkups and that boys may be more likely to recognize the “Hyperactivity/inattention” problem. Based on these results, it is necessary to consider more effective ways of using the SDQ in 5-year-old children’s health checkups, such as evaluating the SDQ scores in combination with the actual condition of the children at the time of the checkup. Disclosure of Interest None Declared

Introduction: Treating mental health problems adequately is of paramount importance given the tremendous burden it places on the individual and on society.Knowing and realizing there is no one size-fits-all-solution, some methods do yield better results.The yardstick as such can be interpreted with scores on questionnaires, subjective accounts and/or having the need for further future follow-up treatments.Objectives: Within the Yes We Can Clinics, based in the Netherlands, we provide a very intensive 10-week residential treatment program where clients learn to acknowledge their problems and get to the root of these problems.The program is centered around confrontation in group sessions from counselors and peers, a wellthought out activity program from early morning till late evening, multiple psychotherapeutic sessions on a daily basis and if possible, minimize the use of medication.Methods: Different Routine Outcome Measurement tests were applied.
Results: Here we measured willingness to participate in the program, which fluctuates from average to low at the start, reaching a significant low motivational point after 2/3 weeks, in accordance with the quintessential confrontational aspect, but following the principles of the program in combination with reconnecting with parents and family (systems-approach), a tremendous increase in willingness and commitment towards the program, but also towards life and facing mental health struggles in general, arises.Conclusions: Herewith confirming the effectiveness of our intensive, immersive, confrontational and protocolized 10-week residential program for youth with mental health problems Disclosure of Interest: None Declared EPP0140 Psychometric Properties of the Parent Versions of the Japanese Versions of the Strength and Difficulties Questionnaire: A study on Health Checkups for 5-Year-Old Children in Japan Introduction: In Japan, the effectiveness of health checkups for children aged 5 years has attracted attention as the basis for a support system for early detection and support of children with developmental disabilities.However, these have not yet become statutory health checkups, and their assessment has not been standardized.This study employed the Strength and Difficulties Questionnaire (SDQ) in examining the health of a 5-year-old child.This study aims to demonstrate the scores' distribution and obtain the standard land and cutoff values of the SDQ.Objectives: From 2010 to 2012, children reaching 5 years of age in Kanie-cho, Aichi Prefecture, Japan, underwent a health checkup.Of the 888 children for whom parental consent was obtained, 884 responses without missing values (453 boys: 51.2%, 430 girls: 48.6%) were included in the analysis.Methods: SDQ and medical questionnaires for 5-year-old children were sent to the parents with a formal request for approval for the child to participate in the study.Further, the parents were asked to respond to the questionnaire.The Ethics Committee of the Graduate School of Education and Developmental Sciences, Nagoya University approved this study (No.298).Results: A confirmatory factor analysis using the maximum likelihood method revealed a factor structure almost identical to that of Goodman (JCPP 1997;38 581-586).Nonetheless, items 3, 10, 11, 13, 14, and 22 showed high loadings on factors different from those in the original version.Similar to the original version, we set our criteria so that Some and High Needs would be approximately 10% each.Furthermore, we calculated the percentage of children who fell into these categories and found that the scores that fell into the Need category differed from those in the previous study(Table 1).Image: Conclusions: Although the five-factor structure of the SDQ was generally accepted, as pointed out in previous studies (Matsuishi et al. Brain Dev 2008;30 410-415 : Iida et al. 2014;33-41), differences in expression between English and Japanese and cultural differences may have influenced the results.Therefore, it is necessary to be careful in interpreting the results.Additionally, the differences in the Need classification indicated that the difficulty level tends to be slightly lower in the 5-year-old children's health checkups and that boys may be more likely to recognize the "Hyperactivity/inattention" problem.Based on these results, it is necessary to consider more effective ways of using the SDQ in 5-year-old children's health checkups, such as evaluating the SDQ scores in combination with the actual condition of the children at the time of the checkup.

EPP0141
Use of Methylphenidate to Improve Cognition in Autism Spectrum Disorder (ASD) S. Ashraf1 , A. Bachu2 , S. Srinivas3 , W. Tankersley4 and K. Shah5 * Introduction: Methylphenidate (MPH) is used to treat attention deficit hyperactivity disorder (ADHD) and has shown unique benefits in children and adolescents with autism spectrum disorder (ASD).In addition to improving attention, hyperactivity, and repetitive movement, it also improves cognition in ASD.Our focus is to explore the understudied benefits and safety of methylphenidate use for cognition in ASD children.
Objectives: 1) To study the response and benefit of methylphenidate in autistic kids to improve cognition and life function.
2) To assess the safety profile and risks of using methylphenidate at different doses in children with autism as a guiding tool for prescribing physicians.Methods: A literature search was conducted using relevant medical subject headings (MeSH) terms in PubMed, Medline, and PubMed Central.We identified all published articles from inception until September 30, 2022.Initial search results found 41 studies, of which 15 were excluded as they did not meet inclusion and exclusion criteria.After a thorough full-text review, we included 5 studies in our final qualitative synthesis review.Results: Methylphenidate was found to have the unique benefit of increasing cognitive processing speed, thus improving everyday life function in ASD and ADHD children compared with only ADHD, with a clinical significance of p<0.001.Stimulants may improve the processing of social situations and interactions or social functions due to this unique response (Peled, J et al. Nordic journal of psychiatry 2020; 74(3), 163-167) A clinically significant performance gain on cognitive tasks was identified with a linear doseresponse at three different doses (10 mg, 15 mg, 20 mg) of methylphenidate.ASD children with ADHD made significantly fewer omission errors, [F(3,69) = 7.21, p < 0.001], and commission errors [F(3,69) = 4.64, p = 0.005] on MPH, compared to placebo.They also showed more response at higher MPH doses, [F(3,69) = 10.45,p < 0.001].Thus, the children were faster, more accurate, and had fewer errors at higher MPH doses (Pearson, D. A. et al.Journal of child and adolescent psychopharmacology 2020; 30(7), 414-426).There were no serious side effects or suicidality reported for low dose and a medium dose of MPH in ASD children assessed with Response Impressions and Side Effects Checklist-Kids (RISC-K), A 38-item parent rating scale (Kim, S. J. et al.Journal of autism and developmental disorders 2017; 47(8), 2307-2313).Conclusions: The findings support the positive response of methylphenidate on cognitive function in ASD children.No serious adverse effects or suicidality were noted.Multi-center welldesigned studies are recommended to determine further efficacy and safety of MPH in ASD children for cognition.Disclosure of Interest: None Declared